Of note, previous studies have demonstrated that activation of Sp1 is unique for transcriptional regulation of DR5 without affecting DR4 expression in other cancer cells, including colon [41], hepatoma [43] and ovarian cancer cells [42]. This evidence concerns the gene TNFRSF10A and hepatocellular carcinoma.